Subscribe To
Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535
Initial results from BDTX-1535 dose escalation show durable activity in patients with NSCLC across heterogeneous EGFR mutation subtypes No new safety or tolerability signal reported across all three active once daily doses of 100mg, 200mg and 300mg Initial NSCLC expansion cohort data expected in 2024 Initial GBM dose escalation data expected later this year CAMBRIDGE, Mass. […] The post Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCL...
Read More
Content Topics
Black
Diamond
Therapeutics
Presents
Dose
Escalation
Data
Demonstrating
Durable
Responses
Patients
Bdtx 1535
Forex
Posted: Oct 14 2023, 16:30
Author Name: forextv
Views: 092022